News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes Mellitus HONG KONG - April 15, 2025 (NEWMEDIAWIRE) - HighTide ...
Diabetes mellitus is most commonly known as diabetes, which is a disease that affects how the body uses glucose or blood ...
Week99er on MSN8d
Retatrutide (LY3437943): A Comprehensive Review of Its Therapeutic Potential in Obesity and Type 2 Diabetes MellitusThe escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...
News-Medical.Net on MSN7d
Are food additives linked to type 2 diabetes?This study identifies food additive mixtures associated with higher type 2 diabetes risk, urging a reevaluation of safety ...
inews.co.uk on MSN5h
The complications from diabetes - and what you can do to prevent itUnlike type 1, type 2 diabetes can sometimes be prevented. According to the charity Diabetes UK, research has shown for some ...
Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.
Type 5 diabetes, which affects lean and undernourished young adults in low- and middle-income countries, has now been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback